Tag: Mayo Clinic

DMC EDA Announces Appointment of New Board Members

December 14, 2022 – ROCHESTER, MINN. – Destination Medical Center Economic Development Agency is announcing the appointment of two new board members. Roberta (Bobbie) Dressen, president and CEO of the Medical Alley Association, and Dennis Dahlen, CFO of Mayo Clinic, will begin their 3-year terms on January 1, 2023. They will be replacing Harry Hoffman and Jerry Bell, who will be stepping down at the end of this year.

“We are delighted to welcome Bobbie Dressen and Dennis Dahlen to the DMC EDA board,” said Dr. Clark Otley, president of DMC EDA. “With their incredible accomplishments and breadth of experience, Bobbie and Dennis will be excellent contributors to the success of the Destination Medical Center initiative.”

Roberta (Bobbie) Dressen - DMC EDA Board of Directors Appointee
Roberta Dressen

Roberta (Bobbie) Dressen has been with the Medical Alley Association since 2021. Prior to that, she held leadership roles with Allina Health Systems, UnitedHealth Group, Boston Scientific, and Medtronic. Ms. Dressen holds an M.B.A. from the University of St. Thomas.

“As the DMC continues to make huge strides in positioning our region as the epicenter of health innovation and care, it’s an honor to be named to the board to help support our shared objectives,” said Dressen. “In addition to my role at Medical Alley, I feel my background in representing various sectors within health care will contribute to building a global destination for the industry and bring more prosperity to the state.”

Dennis E. Dahlen - DMC EDA Board of Directors Appointee
Dennis E. Dahlen

Dennis Dahlen serves as chief financial officer of Mayo Clinic. Before joining Mayo Clinic in 2017, Mr. Dahlen held the same position at Banner Health, an integrated healthcare delivery system in Phoenix, after serving in several other executive positions with Banner since 1999. Mr. Dahlen earned an M.B.A. in finance from Minnesota State University, Moorhead.

“It is an honor to join the DMC EDA at a time when Mayo Clinic is investing in transforming health care,” says Dahlen. “When I came to Mayo in 2017, I was struck by the teamwork and collaboration at Mayo but also the collaboration and thoughtful approach being taken by DMC to secure Rochester, Minnesota as a premier destination for health and wellness now and in the future. We are collectively committing to delivering an unmatched experience for patients, visitors, and residents and that commitment will continue to enhance Rochester’s position as a destination medical center.”

Dressen and Dahlen will be joining current DMC EDA board members Traci Downs, chair of Collider Foundation; Tom Fisher, Director, Minnesota Design Center & Dayton-Hudson Chair in Urban Design, University of Minnesota; Joselyn Raymundo, Founder/President, Rochester Home Infusion; Patrick Seeb, Executive Director, DMC EDA; Mary Jo Williamson, Chief Administrative Officer, Mayo Clinic Collaborative Services; and DMC EDA President Dr. Clark Otley, Chief Medical Officer, Mayo Clinic Platform; Medical Director, Department of Business Development; Consultant, Department of Dermatology, Division of Dermatologic Surgery; Professor of Dermatology, Mayo Clinic College of Medicine and Science; and President, Mayo Foundation for Medical Education and Research

###

About DMC

Destination Medical Center (DMC) is the largest public-private economic initiative in Minnesota’s history. The 20-year plan to transform Rochester into a global destination for health and wellness will attract developers, investors, startups, and entrepreneurs to live, work, and play in America’s City for Health. Destination Medical Center Economic Development Agency is a private non-profit established to provide experience and expertise in developing and marketing on behalf of Destination Medical Center Corporation. For more information, visit dmc.mn.

 

About Medical Alley Association

Medical Alley is The Global Epicenter of Health Innovation and Care®, where healthcare leaders call home. In Medical Alley, you will find the world’s leading health technology innovation cluster, the highest ranked hospital, and the globally recognized Destination Medical Center. Medical Alley is also home to the nation’s largest private health insurer and more than 1,000 healthcare companies, employing more than 500,000 Minnesotans and millions more worldwide.

 

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing.

Rochester innovators find support in community

Vyriad’s co-founders, Drs. Kah-Whye Peng and Stephen Russell

Mayo Clinic is an economic engine for its hometown of Rochester, Minnesota. The health care research leader is the city’s largest employer and the largest driver of visitors to the region, with an estimated 1.2 million patients and their families traveling annually to the region to receive care. But Mayo Clinic’s economic reach extends beyond these direct impacts, sparking the development of businesses in multiple industries.

Mayo Clinic has spun out a number of health-related businesses. More than 170 startups have used intellectual property developed at Mayo Clinic, and more than 2,000 technologies are available for licensing, according to Mayo Clinic Ventures, the organization that manages this commercialization.

Mayo Clinic, Boston Scientific Launch Effort to Accelerate New Medical Technology in DMC’s Discovery Square

 Mayo Clinic and Boston Scientific Corp. have launched a new venture to accelerate the development of medical technology and new minimally invasive treatments for many health conditions that impede quality and longevity of life.

The accelerator, known as Motion Medical, will have its research facilities in One Discovery Square, the bioscience center in the Discovery Square research district. Both parties have committed millions of dollars over three years to develop and bring new solutions to the market to address unmet medical needs. 

“Mayo Clinic is committed to accelerating the pace of discoveries to bring new technologies and treatments to patients faster,” said Gianrico Farrugia, M.D., president and CEO of Mayo Clinic. “This collaboration and others like it will continue to strengthen Rochester and Minnesota as a biomedical innovation and economic powerhouse.”

This venture is another step forward in the collaboration between Mayo Clinic and Boston Scientific Corp., combining Mayo Clinic’s world-class clinical experience and patient care with Boston Scientific’s extraordinary engineering, innovation and business expertise.

“This collaboration between Mayo Clinic and Boston Scientific builds on our experience working together to support the shared goal of advancing patient-centered innovation,” says Mike Mahoney, chairman and CEO, Boston Scientific. “This approach combines the unique strengths of our two organizations, and we look forward to working together to solve complex health care challenges.”

The accelerator, spreading over 1,800 square feet, will be a key tenant in One Discovery Square, developed by Mortenson. The building anchors the 16-block Discovery Square research district for the $5.6 billion Destination Medical Center (DMC) economic development initiative in Rochester, MN. The accelerator is expected to open in the fall.

“Mayo Clinic and Boston Scientific’s new accelerator collaboration is another powerful example of DMC’s vision for Discovery Square being realized as an economic engine and a catalyst to attract new talent and innovative companies to Rochester, Minnesota,” said Lisa Clarke, executive director, DMC Economic Development Agency.

Mayo Clinic and Boston Scientific Corp. have collaborated for nearly a decade to develop new devices and technologies in areas such as interventional cardiology, neuromodulation and urology. Together the companies have filed eight patent applications and collaborated on two first-in-human clinical trials.

 

Anna-Maria and Stephen Kellen Foundation’s $32 Million Gift Advances Mayo Clinic Research

By permission of Mayo Foundation for Medical Education and Research. All rights reserved.

A generous $32 million gift from the New York-based Anna-Maria and Stephen Kellen Foundation will enable Mayo Clinic to expand its research mission with the construction of a four-story, 64,000-square-foot research building in Rochester.

Planning for the Anna-Maria and Stephen Kellen Building is underway, with groundbreaking expected in 2020 and occupancy in 2022. The building will be located just north of Mayo Clinic’s Opus Building, which is on the corner of Fourth Street Southwest and Fourth Avenue Southwest in Rochester.

“We cannot overstate our gratitude to the Anna-Maria and Stephen Kellen Foundation,” says Gianrico Farrugia, M.D., Mayo Clinic’s president and CEO. “Research is critical to infusing new knowledge into patient care. It paves the way to solve serious or complex medical challenges for our patients at Mayo as well as patients around the world. This remarkable gift will allow us to meet a critical need for research space on our Rochester campus.”

The gift was directed to Mayo Clinic by Michael M. Kellen, foundation president, and Marina Kellen French, vice president. Their parents, Anna-Maria and Stephen Kellen, now deceased, received care at Mayo Clinic for decades, and that trust and care have continued into the next three generations. Stephen M. Kellen was president and CEO of Arnhold and S. Bleichroeder Inc., an international investment firm based in New York, now known as First Eagle Investment Management LLC.

“Our family’s history with Mayo Clinic spans more than four decades, and the physicians and staff at Mayo have become like family to us,” says Marina Kellen French. “We are thrilled to be able to support Mayo and be part of advancing medical research that will help patients for decades to come.”

The Anna-Maria and Stephen Kellen Foundation has been a significant contributor to Mayo Clinic over many years, funding various initiatives and projects in support of Mayo Clinic’s highest priorities. The foundation also has supported the Dr. Richard F. Emslander Professorship at Mayo Clinic College of Medicine and Science in recognition of the care that Richard Emslander, M.D., provided to the family over many years.

“Medical research has always been a strong interest of our family,” says Michael M. Kellen. “We are pleased that this gift will address a high-priority need at Mayo while honoring our parents’ legacy in a visible and meaningful way.”

The Anna-Maria and Stephen Kellen Building will add to the Discovery Square sub-district in downtown Rochester. Discovery Square is the research, innovation and development hub of the $5.6 billion Destination Medical Center (DMC) initiative.

“The new Anna-Maria and Stephen Kellen Building will bring more Mayo Clinic expertise to DMC’s Discovery Square and complements the unique entrepreneurial environment of the subdistrict,” adds Lisa Clarke, executive director, DMC Economic Development Agency.

Decisions regarding specific use and occupancy of the new building will be made as part of the planning process this year.

Business Innovation with an “Eye” on Improving Vision

If eyes are the window to the world, Timothy W. Olsen, M.D. is building high performance window frames. With a passion for restoring vision, the ophthalmologist set sights on developing and bringing to market a first-of-its-kind device for treating age-related macular degeneration. The synergies around the Destination Medical Center economic initiative and Mayo Clinic’s research and practice community prompted him to move his business and clinical/surgical practice from Atlanta to Rochester, Minnesota.

“The business environment is second to none. Mayo has made a statement through Destination Medical Center that it wants to be an innovation center for medical technology,” says Dr. Olsen.  “That combination of business, technology and connection to Medical Alley bio businesses in Minnesota makes this is a really good place to develop and commercialize medical devices.”

Destination Medical Center is a 20-year, multibillion dollar public-private partnership to position Rochester as a global destination for health care, biotechnology and life science discoveries. The money supports public infrastructure and does not go to Mayo Clinic. The convergence of entrepreneurship, medical expertise and regulatory support, Dr. Olsen says, is the perfect place for a successful product launch.

“Destination Medical Center is the City of Rochester, Olmsted County and the state of Minnesota. With those components, hopefully there will be private sector support as well as the opportunity for engaging with people involved in funding early stage start-up companies, including venture capital funding opportunities,” says Dr. Olsen.

A new device for age-related macular degeneration

Macular degeneration affects more than 3 million Americans and is the leading cause of vision loss for people over 50. There is no cure or treatment in the early stages. Patients with end-stage macular degeneration may be suitable for monthly eye injections, but that is expensive and inconvenient. The disease process usually progresses despite the injections.   

That’s where Dr. Olsen’s business comes in. His team is advancing research on a surgically implantable device, using a technology that was first conceived at the University of Minnesota and patented through Emory University. That device acts as a window or picture frame holding regenerative tissue in place to support the macula at the back of the eye, potentially reversing vision loss and preserving the function of the macula.  

The National Institutes of Health/National Eye Institute awarded a Small Business Technology Transfer grant for a one year, phase one feasibility study. The grant goes directly to Dr. Olsen’s company, located in the Mayo Clinic Business Accelerator, with sub grant funding for pre-clinical research at Mayo.

“The goal of this research grant is to support scientists launching commercialization of a product rather than the researcher studying technology from an outside company, in an effort to speed the movement of a product from the research lab into the marketplace,” says Dr. Olsen.

Reaching new heights through collaboration

Rendering of Gonda Building upon completion of additional floors

Mayo Clinic has announced plans to collaborate with Singapore-based real estate developer Pontiac Land Group to expand the clinic’s Gonda Building. The collaboration will advance Mayo Clinic’s expansion plans by nearly a decade. The 11-floor vertical expansion will include four floors dedicated to new clinical space and seven floors that will house a premier hotel.

“The expansion of the Gonda Building on Mayo Clinic’s downtown Rochester campus to accommodate new clinical space and a new hotel are wonderful additions to Destination Medical Center’s Heart of the City,” says Destination Medical Center Economic Development Agency Executive Director Lisa Clarke. “This unique collaboration – and Pontiac Land Group investing here – also continues to prove that Rochester is an attractive market for investors and developers from around the globe.”

While details are still being finalized, preliminary plans indicate construction will begin in late 2019 or early 2020.

Click here to learn more about this exciting new downtown Rochester, Minnesota development.

Gianrico Farrugia, M.D., elected as new president and CEO, Mayo Clinic

Dr. Gianrico Farrugia
Dr. Gianrico Farrugia
ROCHESTER, Minn. — The Mayo Clinic Board of Trustees announced on Friday, Aug. 10, that it has elected Gianrico Farrugia, M.D., (JAN-ree-koh fa-ROO-jah), vice president, Mayo Clinic, and CEO of Mayo Clinic in Florida to succeed John Noseworthy, M.D., as president and CEO, Mayo Clinic. Dr. Noseworthy remains president and CEO, Mayo Clinic, through his retirement at the end of the year. Drs. Noseworthy and Farrugia will work closely together through this period of transition…

Shared Value Award addresses community health issues

Mayo Clinic has been identifying and addressing community health issues, such as mental health, immunizations, and obesity, for decades. This year, they’re asking you to get involved.

The Mayo Clinic Shared Value Award was created in 2016 to help solve some of the unique community health needs of Rochester and Olmsted County as well as to encourage collaboration among local groups. Up to $50,000 is given annually to a partnership of three or more organizations who are working together to improve health and vibrancy in Olmsted County. In past years, award winners were chosen solely by Mayo Clinic, but this year’s award will be chosen as part of a community-wide vote.

Accelerating health innovation at Transform

On September 26-27, 2018, Rochester, Minnesota will again lead the way as the epicenter for health care innovation, as Mayo Clinic’s Transform 2018 comes to the Mayo Civic Center.

For more than a decade, Transform has been the preeminent health care conference for people to proactively confront critical issues, share meaningful insights, and accelerate health innovation.

This year, Transform will feature industry experts to explore pivotal opportunities in the key areas of augmented human intelligence, making innovation possible within organizations, and how to help people live their best lives.